Drug intelligence / Profile preview

FiberBind

Development stage: Unknown
Lead developer: KMC
Modality: Small Molecules
Administration: Oral

Overview

FiberBind is a bulk-forming laxative and dietary fiber supplement. It is used to treat constipation by increasing the bulk and water content of stool, making it softer and easier to pass. Bulk-forming laxatives like FiberBind work by absorbing water in the intestines, which helps promote bowel movements. These products are generally taken orally with plenty of fluids to prevent choking or blockage. They may also be used as part of dietary fiber supplementation for general digestive health or to help manage diarrhea by normalizing stool consistency.

Brand names: FiberBind

Beyond the preview

Go deeper on FiberBind.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FiberBind.

Explore the full profile